Grant Pickering - Jan 27, 2022 Form 4 Insider Report for Athira Pharma, Inc. (ATHA)

Role
Director
Signature
Glenna Mileson, Attorney-in-fact for Grant Pickering
Stock symbol
ATHA
Transactions as of
Jan 27, 2022
Transactions value $
$0
Form type
4
Date filed
1/31/2022, 04:04 PM
Previous filing
Dec 28, 2021
Next filing
Mar 4, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ATHA Stock Option (Right to Buy) Award $0 +27.7K $0.00 27.7K Jan 27, 2022 Common Stock 27.7K $9.91 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 One thirty-sixth of the shares subject to the option will vest on February 27, 2022 and one thirty-sixth of the shares subject to the option will vest each month thereafter.